PHARMACIE CH. HARDY
0464.924.364 · rovalta.com · 28/09/2026
PHARMACIE CH. HARDY
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBOPHARMACIE CH. HARDY is a company registered in Belgium. It employs on average 2,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0464.924.364
- Legal form
- Public limited company
- Contributed capital
- 61 973,38 €
- Latest accounts
- 31/12/2023
- Average workforce
- 2,5 ETP
Financials
Source · NBB, 26 filingsTrend over 18 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 495,3 k € | +3.4% | 478,9 k € | +40.6% | 340,7 k € | +46.6% | 232,5 k € | +50.2% | 154,7 k € |
| EBITDA | 310 k € | +2.8% | 301,4 k € | +45.0% | 207,9 k € | +49.3% | 139,2 k € | +126% | 61,6 k € |
| Operating result | 272,3 k € | +3.6% | 262,8 k € | +46.7% | 179,2 k € | +48.3% | 120,8 k € | +173% | 44,3 k € |
| Net result | 200,8 k € | +5.0% | 191,1 k € | -79.5% | 931,5 k € | +878% | 95,2 k € | +193% | 32,5 k € |
| Balance sheet | |||||||||
| Equity | 1,5 M € | +15.8% | 1,3 M € | +0.9% | 1,3 M € | +234% | 376,8 k € | +10.3% | 341,6 k € |
| Total assets | 2 M € | -3.0% | 2,1 M € | +6.0% | 2 M € | +100% | 989,7 k € | -6.2% | 1,1 M € |
| Cash | 76,1 k € | -44.5% | 137,2 k € | +220% | 42,9 k € | +126% | 19 k € | -73.9% | 72,9 k € |
| Debts | 568,4 k € | -31.6% | 831,4 k € | +14.8% | 724,1 k € | +18.8% | 609,6 k € | -14.2% | 710,2 k € |
| Other | |||||||||
| Workforce | 2,5 ETP | 0.0% | 2,5 ETP | +25.0% | 2,0 ETP | +33.3% | 1,5 ETP | 0.0% | 1,5 ETP |
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Managing director21/04/2006 → 15/05/2029 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Chantal HARDY | Director29/06/2018 → 21/04/2024 | ||
| Managing director29/06/2018 → 21/04/2024 | |||
Olivier BUSTIN | Director29/06/2018 → 21/04/2024 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/07/2024 | 22/05/2023 | 16/07/2022 | 27/08/2021 | 20/08/2020 | 28/07/2019 |
| General meeting | 21/06/2024 | 12/05/2023 | 17/06/2022 | 28/05/2021 | 26/06/2020 | 21/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 26 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 21/06/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 12/05/2023 | 22/05/2023 | French | |
| Abridged model | 31/12/2021 | 17/06/2022 | 16/07/2022 | French | |
| Abridged modelCorrection | 31/12/2020 | 28/05/2021 | 27/08/2021 | French | |
| Abridged model | 31/12/2020 | 28/05/2021 | 10/06/2021 | French | |
| Abridged model | 31/12/2019 | 26/06/2020 | 20/08/2020 | French | |
| Abridged model | 31/12/2018 | 21/06/2019 | 28/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 16/08/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 29/08/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 20/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/06/2015 | 03/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 20/08/2014 | French | |
| Abridged model | 31/12/2012 | 21/06/2013 | 22/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 28/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 03/08/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 18/07/2010 | French | |
| Abridged model | 31/12/2008 | 19/06/2009 | 07/08/2009 | French | |
| Abridged model | 31/12/2007 | 20/06/2008 | 08/08/2008 | French | |
| Abridged model | 31/12/2006 | 15/06/2007 | 28/08/2007 | French | |
| Abridged model | 31/12/2005 | 21/04/2006 | 02/08/2006 | French | |
| Abridged model | 31/12/2004 | 15/04/2005 | 27/05/2005 | French | |
| Abridged model | 31/12/2003 | 16/04/2004 | 01/06/2004 | French | |
| Abridged model | 31/12/2002 | 18/04/2003 | 18/06/2003 | French | |
| Abridged model | 31/12/2001 | 19/04/2002 | 20/08/2002 | French | |
| Abridged model | 31/12/2000 | 20/04/2001 | 01/08/2001 | French | |
| Abridged model | 31/12/1999 | 21/04/2000 | 17/10/2000 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Managing director21/04/2006 → 15/05/2029 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Chantal HARDY | Director29/06/2018 → 21/04/2024 | ||
| Managing director29/06/2018 → 21/04/2024 | |||
Olivier BUSTIN | Director29/06/2018 → 21/04/2024 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution23/07/2024DISSOLUTION
- Restructuring27/05/2024Projet commun de fusion
- Mandates30/01/2024SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Other17/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES
- Mandates25/06/2021DEMISSIONS, NOMINATIONS
- Mandates08/01/2019DEMISSIONS, NOMINATIONS
- Mandates20/02/2013DEMISSIONS, NOMINATIONS
- Mandates20/01/2012DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de Mangombroux 161, 4800 Verviers | accounts 2023 | Accounts 2023 · 2024-00253613 |
| Rue des Grands Champs 6, 4420 Saint-Nicolas (Liège) | accounts 2021 → 2022 | Accounts 2022 · 2023-00093474 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMACIE SANTIS SAINT NICOLAS | accounts 2023 | Accounts 2023 · 2024-00253613 |
| PHARMACIE CH. HARDY | accounts 2021 → 2022 | Accounts 2022 · 2023-00093474 |
Events
- 2023Annual accounts 2023200,8 k €↑
- 2023Name changePHARMACIE SANTIS SAINT NICOLAS
- 2022Annual accounts 2022191,1 k €↓
- 2021Annual accounts 2021931,5 k €↑
- 2020Annual accounts 202095,2 k €↑
- 2019Annual accounts 201932,5 k €↓
- 2018Annual accounts 2018105,4 k €↑
- 2017Annual accounts 201773,7 k €↓
- 2016Annual accounts 2016103,4 k €↑
- 2015Annual accounts 201585,5 k €↓
- 2014Annual accounts 2014100,5 k €↑
- 2013Annual accounts 201383,4 k €↓
- 2012Annual accounts 2012103,7 k €↑
- 2011Annual accounts 201179,7 k €↑
- 2010Annual accounts 201017,4 k €↓
- 2009Annual accounts 200973,7 k €↓
- 2008Annual accounts 200878 k €↓
- 2007Annual accounts 2007137,5 k €↑
- 2006Annual accounts 2006128,4 k €